Reported May 5, 2021 · Terminated
Trinity Biotech Captia Measles IgM Kit, Catalog No. 2326060 - Product Usage: intended for the qualitative detection of…
Clark Laboratories, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Clark Laboratories, Inc. · 2823 Girts Rd · Jamestown, NY · 14701-9666
Is this the product you have?
- Trinity Biotech Captia Measles IgM Kit, Catalog No. 2326060 -
- Product Usageintended for the qualitative detection of Measles igM antibodies in human serum of patients suspected of measles (rubeola) infection
- Lot codes and dates
- Kit Lot2326060-060
- Expiration Date2021-06-28 (UDI): 05391516743655
- Amount recalled
- 80 kits
Where it was sold
- Nationwide
Why it was recalled
Positive Control may run high out of its assigned ISR range and result in an invalid run and necessitate retesting
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Clark Laboratories, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.